Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-02-28 to 2022-03-01
Current total value of award: $210.53
Description: 4556393062!LAMISIL 1% CRM 30GM 1S